Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Sign In or Create an Account The patents kept the cost of those drugs high because Danish drug manufacturer Novo Nordisk was the only company that could make them
This broad action helps it address various metabolic aspects simultaneously, providing more than just a singular benefit and making it an effective choice for comprehensive health care
Medical Disclaimer This article is for educational purposes only and does not constitute medical advice
In this randomized, double-blind, and placebo-controlled trial, the peptide demonstrated unprecedented results over a 48-week period: Significant Weight Reduction: In the highest dosage group evaluated, a dose-dependent reduction in body weight of up to 24.2% was achieveda figure that significantly surpasses previously published results for comparable substances in obesity and metabolic research
The agency said the crackdown intends to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The Department of Health and Human Services general counsel Mike Stuart, tweeted that the agency had reviewed the matter and referred Hims & Hers to the Department of Justice for investigation for potential violations of the Federal Food, Drug, and Cosmetic Act